WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Stock Ownership - Who owns Abeona Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Abeona Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Vishwas SeshadriChief Executive Officer2025-03-3125,000$4.78
$119.50kSell
Joseph Walter VazzanoChief Financial Officer2025-03-14685$5.29
$3.62kSell
Brendan M. OmalleySVP General Counsel2025-03-03181$5.24
$948.44Sell
Mark AlvinoDirector2025-01-294,000$5.38
$21.52kSell
Mark AlvinoDirector2025-01-214,000$5.10
$20.40kSell
Vishwas SeshadriChief Executive Officer2024-10-16251$6.54
$1.64kSell
Brendan M. OmalleySVP General Counsel2024-09-286,579$5.89
$38.75kSell
Joseph Walter VazzanoChief Financial Officer2024-09-286,388$5.89
$37.63kSell
Vishwas SeshadriChief Executive Officer2024-09-2818,798$5.89
$110.72kSell
Brendan M. OmalleySVP General Counsel2024-09-20496$6.02
$2.99kSell

1 of 2

ABEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABEO insiders and whales buy or sell their stock.

ABEO Shareholders

What type of owners hold Abeona Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sco Capital Partners LLC29.65%14,390,007$76.27MInsider
Steven H. Rouhandeh28.80%13,977,076$74.08MInsider
Adage Capital Partners GP LLC8.04%3,902,360$20.68MInstitution
Suvretta Capital Management LLC7.59%3,685,503$19.53MInstitution
Nantahala Capital Management LLC7.27%3,529,214$18.70MInstitution
Adage Capital Partners GP LLC6.70%3,249,994$17.22MInsider
Ayer Capital Management LP4.97%2,413,163$12.79MInsider
Millennium Management LLC4.36%2,117,169$11.22MInstitution
Western Standard LLC4.29%2,084,418$11.05MInstitution
Vanguard Group Inc4.05%1,966,023$10.42MInstitution

1 of 3

ABEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABEO41.85%58.15%Net SellingNet Selling
BNTC81.01%8.93%Net BuyingNet Buying
TPST11.85%88.15%Net Selling
RNAC14.07%85.93%Net BuyingNet Buying
SEPN66.05%33.95%Net BuyingNet Buying
View Top Biotech Stocks

Abeona Therapeutics Stock Ownership FAQ

Who owns Abeona Therapeutics?

Abeona Therapeutics (NASDAQ: ABEO) is owned by 63.12% institutional shareholders, 87.69% Abeona Therapeutics insiders, and 0.00% retail investors. Sco Capital Partners LLC is the largest individual Abeona Therapeutics shareholder, owning 14.39M shares representing 29.65% of the company. Sco Capital Partners LLC's Abeona Therapeutics shares are currently valued at $94.40M.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.